Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.
复制标题
DOI:
10.1038/s41467-017-01385-8
复制
发表时间:
2017-11-09
影响因子:
16.6
通讯作者:
Wang Y
中科院分区:
文献类型:
--
作者:
Wang P;Li X;Wang J;Gao D;Li Y;Li H;Chu Y;Zhang Z;Liu H;Jiang G;Cheng Z;Wang S;Dong J;Feng B;Chard LS;Lemoine NR;Wang Y
Interleukin-12 (IL-12) has emerged as one of the most potent agents for anti-tumor immunotherapy. However, potentially lethal toxicity associated with systemic administration of IL-12 precludes its clinical application. Here we redesign the molecule in such a way that its anti-tumor efficacy is not compromised, but toxic effects are eliminated. Deletion of the N-terminal signal peptide of IL-12 can effect such a change by preventing IL-12 secretion from cells. We use a newly designed tumor-targeted oncolytic adenovirus (Ad-TD) to deliver non-secreting (ns) IL-12 to tumor cells and examine the therapeutic and toxic effects in Syrian hamster models of pancreatic cancer (PaCa). Strikingly, intraperitoneal delivery of Ad-TD-nsIL-12 significantly enhanced survival of animals with orthotopic PaCa and cured peritoneally disseminated PaCa with no toxic side effects, in contrast to the treatment with Ad-TD expressing unmodified IL-12. These findings offer renewed hope for development of IL-12-based treatments for cancer. Interleukin-12 (IL-12) is a potent immunotherapeutic agent.
登录
查看更多内容
DOI:
10.1084/jem.177.4.1199
发表时间:
1993-04-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Manetti R;Parronchi P;Giudizi MG;Piccinni MP;Maggi E;Trinchieri G;Romagnani S
通讯作者:
Romagnani S
影响因子:
15.3
作者:
D'Andrea, A;Aste-Amezaga, M;Valiante, N M;Ma, X;Kubin, M;Trinchieri, G
通讯作者:
Trinchieri, G
影响因子:
5.2
作者:
Miao, Jin-Wei;Liu, Li-Jiang;Huang, Jie
通讯作者:
Huang, Jie
影响因子:
24.5
作者:
Gonzalez-Aparicio, Manuela;Alzuguren, Pilar;Hernandez-Alcoceba, Ruben
通讯作者:
Hernandez-Alcoceba, Ruben
影响因子:
15.9
作者:
Heise, C;Kirn, DH
通讯作者:
Kirn, DH